Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

about

Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell line

P2860

Q42370510-FA7BA9B2-5225-46D9-BD6C-4B0A11639629

P2860

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

Item

http://www.wikidata.org/entity/Q54364369

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

@en

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

@nl

type

Item

label

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

@en

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

@nl

prefLabel

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

@en

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

@nl

P1476

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

@en

P2093

A Pardanani

http://www.w3.org/2001/XMLSchema#string

D I Smith

http://www.w3.org/2001/XMLSchema#string

T L Lasho

http://www.w3.org/2001/XMLSchema#string

P2860

PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53

Clonal evolution in hematological malignancies and therapeutic implications

Identification of Akt interaction protein PHF20/TZP that transcriptionally regulates p53

AKT is a therapeutic target in myeloproliferative neoplasms

p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal.

Identification of submicroscopic genetic changes and precise breakpoint mapping in myelofibrosis using high resolution mate-pair sequencing.

p53 regulation of DNA excision repair pathways.

TP53 in hematological cancer: low incidence of mutations with significant clinical relevance.

PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage.

JAK2(V617F) negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms.

P2888

leu.2014.117

P304

1762-1764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2014.117

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ayalew Tefferi

P577

2014-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24675105

http://www.w3.org/2001/XMLSchema#string

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

about

P2860

P2860

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698